Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Clinical trial NCT00146276 · UNKNOWN

Trial details

NCT number: NCT00146276
Sponsor: Association of Urologic Oncology (AUO)
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Cancer Carcinoma, Transitional Cell

Start date: 2000-07-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.